Sermorelin for Women Over 40: Clinical Outcomes vs Marketing Claims
Fat Loss (Visceral) 8–12 weeks Increased lipolysis via GH-mediated hormone-sensitive lipase activation Measurable at therapeutic IGF-1 levels (200+ ng/mL); requires caloric deficit Lean Muscle Retention 12–16 weeks Enhanced protein synthesis; reduced muscle ca
This comparison does not assign a generated winner or score.
- Fat Loss (Visceral)
- 8–12 weeks
- Increased lipolysis via GH-mediated hormone-sensitive lipase activation
- Measurable at therapeutic IGF-1 levels (200+ ng/mL); requires caloric deficit
- Lean Muscle Retention
- 12–16 weeks
- Enhanced protein synthesis; reduced muscle catabolism during caloric restriction
- Effective when paired with resistance training 3x/week minimum
- Skin Elasticity & Thickness
- 16–24 weeks
- Collagen synthesis upregulation; fibroblast activity increase
- Dermatological improvement documented in 60–70% of consistent users
- Sleep Architecture
- 2–4 weeks
- Restoration of slow-wave (deep) sleep phases via GH pulse normalization
- One of the earliest noticeable benefits; improves REM latency
- Bone Density
- 6–12 months
- Osteoblast activity stimulation; calcium retention in trabecular bone
- Requires long-term use; not a substitute for bisphosphonates in osteoporosis